SecSonar.com

Guardian Pharmacy Services, Inc. (GRDN)

Guardian Pharmacy Services, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Guardian Pharmacy Services, Inc. (GRDN) is a Medical - Distribution company based in US with a market capitalization of $2.4B. Revenue grew 17.9% year-over-year and the company generated $80.7M in free cash flow. This page tracks GRDN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 3.4K employees · IPO Apr 21, 2016

Valuation

Valuation & price

$36.61 · as of May 17, 2026 · -15.6% vs 52w high

47.1

P/E ratio

Latest-FY diluted EPS

11.91

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$43.40$31.64$19.88Jul 25Dec 25Jul 26Jul 7, 25$20.74Jul 9, 25$21.09Jul 11, 25$20.40Jul 15, 25$20.55Jul 17, 25$20.81Jul 21, 25$20.89Jul 23, 25$20.70Jul 25, 25$20.55Jul 29, 25$20.33Jul 31, 25$20.90Aug 4, 25$20.26Aug 6, 25$20.94Aug 11, 25$19.88Aug 13, 25$23.55Aug 15, 25$23.62Aug 19, 25$25.40Aug 21, 25$26.29Aug 25, 25$26.23Aug 27, 25$25.76Aug 29, 25$26.42Sep 3, 25$28.41Sep 5, 25$28.21Sep 9, 25$28.84Sep 11, 25$30.30Sep 16, 25$27.26Sep 18, 25$26.42Sep 22, 25$25.35Sep 24, 25$26.21Sep 26, 25$26.01Sep 30, 25$26.23Oct 2, 25$24.42Oct 6, 25$23.75Oct 8, 25$23.70Oct 10, 25$23.41Oct 14, 25$24.42Oct 16, 25$24.37Oct 21, 25$27.05Oct 23, 25$28.03Oct 27, 25$29.05Oct 29, 25$28.55Oct 31, 25$28.04Nov 4, 25$28.49Nov 6, 25$28.49Nov 10, 25$29.75Nov 12, 25$31.55Nov 14, 25$29.21Nov 18, 25$27.91Nov 20, 25$27.64Nov 25, 25$29.36Nov 28, 25$29.28Dec 2, 25$29.28Dec 4, 25$29.32Dec 8, 25$28.62Dec 10, 25$29.92Dec 12, 25$30.18Dec 16, 25$30.64Dec 18, 25$31.15Dec 22, 25$31.38Dec 24, 25$30.86Dec 29, 25$30.98Jan 2, 26$29.53Jan 6, 26$31.28Jan 8, 26$30.94Jan 12, 26$31.51Jan 14, 26$30.13Jan 16, 26$27.03Jan 21, 26$29.35Jan 23, 26$30.51Jan 27, 26$29.71Jan 29, 26$30.68Feb 2, 26$32.37Feb 4, 26$31.44Feb 9, 26$34.09Feb 11, 26$34.59Feb 13, 26$33.46Feb 18, 26$32.83Feb 20, 26$33.54Feb 24, 26$32.43Feb 26, 26$33.07Mar 2, 26$33.66Mar 4, 26$34.76Mar 6, 26$31.78Mar 10, 26$33.65Mar 12, 26$33.27Mar 17, 26$34.09Mar 19, 26$34.39Mar 23, 26$37.26Mar 25, 26$36.50Mar 27, 26$34.16Mar 31, 26$37.66Apr 2, 26$37.99Apr 7, 26$39.26Apr 9, 26$40.65Apr 13, 26$39.49Apr 15, 26$37.09Apr 17, 26$37.54Apr 22, 26$36.26Apr 24, 26$37.57Apr 28, 26$37.59Apr 30, 26$37.10May 4, 26$36.64May 6, 26$36.58May 8, 26$36.09May 12, 26$34.91May 14, 26$36.27May 18, 26$35.82May 20, 26$37.63May 22, 26$38.48May 28, 26$38.75Jun 1, 26$39.26Jun 3, 26$39.14Jun 5, 26$40.48Jun 9, 26$41.83Jun 11, 26$43.08Jun 15, 26$42.88Jun 17, 26$43.40Jun 22, 26$41.89Jun 24, 26$38.33Jun 26, 26$42.31Jul 2, 26$42.00
$19.8852-week range$43.40
Loading valuation history…

Fundamentals

Key fundamentals

$2.4B

Market cap

17.9%

Revenue growth (YoY)

19.5%

Gross margin

$80.7M

Free cash flow (USD)

-$28.5M

Net debt

Net cash position

0.6%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$600.4MFY 2019$698.3MFY 2020$736.0MFY 2021$792.1MFY 2022$908.9MFY 2023$1.0BFY 2024$1.2BFY 2025$1.4B
$600.4M$1.4B

Free cash flow by year

2018 → 2025

FY 2018$33.7MFY 2019$41.6MFY 2020$44.3MFY 2021$49.2MFY 2022$31.8MFY 2023$56.3MFY 2024$41.6MFY 2025$80.7M
$33.7M$80.7M

Gross margin by year

2021 → 2025

FY 202120.4%FY 202220.4%FY 202319.9%FY 202419.9%FY 202519.5%
20.4%19.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventExecutive Leadership ChangesJun 22, 2026Filing
  • 8-K eventLoan Agreement AmendmentMay 28, 2026Filing
  • 8-K eventAnnual Meeting ResultsMay 7, 2026Filing
  • 8-K eventEarnings ReleaseMay 6, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing
  • FinancingSecurities RegistrationMay 6, 2026Filing

Questions

Frequently asked questions

What is Guardian Pharmacy Services, Inc.'s market cap?

Guardian Pharmacy Services, Inc. (GRDN) has a market capitalization of $2.4B.

What is GRDN's P/E ratio?

GRDN trades at a price-to-earnings ratio of 47.1, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is GRDN's price-to-book (P/B) ratio?

GRDN trades at 11.91 times book value per share.

Are insiders buying GRDN stock?

SEC Form 4 filings show no open-market insider buys at Guardian Pharmacy Services, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Distribution

PBH

Prestige Consumer Healthcare Inc.

$2.3B

ACH

Accendra Health, Inc.

$219.4M

GEG

Great Elm Group, Inc.

$67.7M

WGRX

Wellgistics Health, Inc.

$9.2M

SNYR

Synergy CHC Corp.

$2.8M

MEHA

Functional Brands, Inc. Common Stock

$592.9K

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.